Best Prices Anywhere!
Sale!
Obagi Nu-Cil™ Eyelash + Eyebrow Serums
Original price was: £267.00.£239.00Current price is: £239.00.
Supports longer, fuller, thicker, darker eyelashes and eyebrows
Nu-Cil is designed to target the growth phase of the lash cycle to support overall lash improvement. Powered by NouriPlex™ technology (bimatoprost analogue), a unique blend of 4 key ingredients nourish lashes for a more luscious, thicker, and defined appearance with results that continuously build day after day. 3 ml
An eyebrow boosting serum specially formulated to help address thinning, patchy, and over-tweezed brows. Obagi’s NouriPlex™Technology (bimatoprost analogue), a clinically-proven blend of ingredients shown to accentuate the healthy look of eyebrows to be fuller, denser, and darker. 5 ml
Eyelashes and Eyebrows thin over time and can be diminished by over-tweezing and shaping. To add, hair follicles can stop producing hair, hair can deteriorate, lighten in color, and decrease in volume and density. These clinically-proven serums is powered by Obagi's innovative NouriPlex™ Technology which features a complex blend of four high-performance ingredients to target the Anagen phase of the growth cycle. Eyelashe & Eyebrow enhancing serums are most effective during this phase, usually lasting 30-45 days.
The life cycle of hair can be divided into 3 phases: Anagen, Catagen, and Telogen
“Anagen” is the phase in which hair develop and prosper. This phase typically lasts between 30 and 45 days.
By combining 4 powerful ingredients, NouriPlex technology targets the anagen phase to nourish and improve hair like never before.
- NouriPlex Technology a unique combination of ingredients Biotin, Panthenol, Sodium Hyaluronate and a Proprietary Lipid Compound that targets the anagen phase of the hair cycle.
Ingredients: Water (Aqua), Dehydrolatanoprost, Biotin, Panthenol, Sodium Hyaluronate, Phenoxyethanol, C12-15 Alkyl Benzoate, Caprylyl Glycol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Alcohol, Sodium Hydroxide, Phenethyl Caffeate.